John D. Zehren

Director/Board Member at Singlepass, Inc.

Health Technology

Consumer Services

Profile

John D.
Zehren is an Independent Director at Singlepass, Inc. since 2022.
Previously, he was the Chief Commercial Officer at Endologix LLC from 2019 to 2020.
He completed his undergraduate degree at the University of St. Thomas.

John D. Zehren active positions

Companies	Position	Start
Singlepass, Inc. Singlepass, Inc. Medical SpecialtiesHealth Technology Singlepass, Inc. has developed a unique electrocautery device that improves the clinical outcomes of deep tissue biopsy procedures. The company is based in Lake Forest, CA. The patented, single-use device prevents and stops bleeding caused by tissue extraction by cauterizing the tissue channel. It is the only cautery device of its kind that can be used for biopsy procedures. Singlepass was founded by Peter Sunenshine and Kevin Hirsch. The CEO is Bill Colone.	Director/Board Member	2022-03-17

All active positions of John D. Zehren

Former positions of John D. Zehren

Companies	Position	End
ENDOLOGIX, INC.	Corporate Officer/Principal	2020-04-13

See the detail of John D. Zehren's experience

Training of John D. Zehren

University of St. Thomas

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of John D. Zehren's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Endologix LLC Endologix LLC Medical SpecialtiesHealth Technology Endologix LLC engages in the research, development, manufacture, and trade of medical devices for the treatment of aortic disorders such as abdominal aortic aneurysms (AAA). Its products include AFX Endovascular AAA System, Nellix and Ovation. The company was founded in March 1992 and is headquartered in Irvine, CA.	Health Technology
Singlepass, Inc. Singlepass, Inc. Medical SpecialtiesHealth Technology Singlepass, Inc. has developed a unique electrocautery device that improves the clinical outcomes of deep tissue biopsy procedures. The company is based in Lake Forest, CA. The patented, single-use device prevents and stops bleeding caused by tissue extraction by cauterizing the tissue channel. It is the only cautery device of its kind that can be used for biopsy procedures. Singlepass was founded by Peter Sunenshine and Kevin Hirsch. The CEO is Bill Colone.	Health Technology